Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 26 (20), 5044-5050

Brain Penetrant Liver X Receptor (LXR) Modulators Based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole Core

Affiliations

Brain Penetrant Liver X Receptor (LXR) Modulators Based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole Core

Colin M Tice et al. Bioorg Med Chem Lett.

Abstract

Liver X receptor (LXR) agonists have been reported to lower brain amyloid beta (Aβ) and thus to have potential for the treatment of Alzheimer's disease. Structure and property based design led to the discovery of a series of orally bioavailable, brain penetrant LXR agonists. Oral administration of compound 18 to rats resulted in significant upregulation of the expression of the LXR target gene ABCA1 in brain tissue, but no significant effect on Aβ levels was detected.

Keywords: Alzheimer’s disease; Brain; LXR; Structure-based drug design.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

  • Ligands of Therapeutic Utility for the Liver X Receptors
    R Komati et al. Molecules 22 (1). PMID 28067791. - Review
    Liver X receptors (LXRs) have been increasingly recognized as a potential therapeutic target to treat pathological conditions ranging from vascular and metabolic diseases …

Publication types

LinkOut - more resources

Feedback